- Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
- Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024
- Trevi Therapeutics to Participate in Upcoming March Events
- Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Trevi Therapeutics Provides Business Updates
More ▼
Key statistics
As of last trade Trevi Therapeutics Inc (TRVI:NMQ) traded at 3.54, -11.50% below its 52-week high of 4.00, set on Mar 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.47 |
---|---|
High | 3.54 |
Low | 3.39 |
Bid | 3.49 |
Offer | 3.54 |
Previous close | 3.47 |
Average volume | 292.52k |
---|---|
Shares outstanding | 68.96m |
Free float | 68.08m |
P/E (TTM) | -- |
Market cap | 239.29m USD |
EPS (TTM) | -0.2934 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 16:17 BST.
More ▼